+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Statin use and reduced cancer-related mortality



Statin use and reduced cancer-related mortality



New England Journal of Medicine 367(19): 1792-1802



A reduction in the availability of cholesterol may limit the cellular proliferation required for cancer growth and metastasis. We tested the hypothesis that statin use begun before a cancer diagnosis is associated with reduced cancer-related mortality. We assessed mortality among patients from the entire Danish population who had received a diagnosis of cancer between 1995 and 2007, with follow-up until December 31, 2009. Among patients 40 years of age or older, 18,721 had used statins regularly before the cancer diagnosis and 277,204 had never used statins. Multivariable-adjusted hazard ratios for statin users, as compared with patients who had never used statins, were 0.85 (95% confidence interval [CI], 0.83 to 0.87) for death from any cause and 0.85 (95% CI, 0.82 to 0.87) for death from cancer. Adjusted hazard ratios for death from any cause according to the defined daily statin dose (the assumed average maintenance dose per day) were 0.82 (95% CI, 0.81 to 0.85) for a dose of 0.01 to 0.75 defined daily dose per day, 0.87 (95% CI, 0.83 to 0.89) for 0.76 to 1.50 defined daily dose per day, and 0.87 (95% CI, 0.81 to 0.91) for higher than 1.50 defined daily dose per day; the corresponding hazard ratios for death from cancer were 0.83 (95% CI, 0.81 to 0.86), 0.87 (95% CI, 0.83 to 0.91), and 0.87 (95% CI, 0.81 to 0.92). The reduced cancer-related mortality among statin users as compared with those who had never used statins was observed for each of 13 cancer types. Statin use in patients with cancer is associated with reduced cancer-related mortality. This suggests a need for trials of statins in patients with cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055911414

Download citation: RISBibTeXText

PMID: 23134381

DOI: 10.1056/nejmoa1201735


Related references

Statin use and reduced cancer-related mortality. New England Journal of Medicine 368(6): 574-574, 2013

Statin use and reduced cancer-related mortality. New England Journal of Medicine 368(6): 574-575, 2013

Statin therapy and cancer-related mortality. Der Internist 54(9): 1152-1154, 2013

High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States. Urologic Oncology 27(2): 170-173, 2008

Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study. European Heart Journal 37(11): 908-916, 2016

Statin use is associated with reduced mortality in COPD. European Respiratory Journal 29(2): 279-283, 2007

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 153(4): 573-578, 2007

Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy. Breast Cancer Research and Treatment 89(1): 61-67, 2005

Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease. Plos one 10(10): E0140571, 2015

An extensive English study: reduced cardiovascular mortality and morbidity by statin. Lakartidningen 98(51-52): 5846-5850, 2001

Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis. American Journal of Medicine 125(11): 1111-1123, 2012

Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular 14(1): 1-8, 2006

Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetes. Medical Care 45(4): 308-314, 2007